Volume 7, Issue 3 (9-2018)                   3dj 2018, 7(3): 103-108 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ashraf H, Mojtahed Bidabadi M, Noghlachi T, Darmiani S. Controlling Postendodontic Pain in Comparison to Placebo: A Randomized Double-blind Clinical Trial. 3dj 2018; 7 (3) :103-108
URL: http://3dj.gums.ac.ir/article-1-320-en.html
1- Professor, Department of Endodontics, Shool of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2- Endodontist.
3- DDS, Dentist.
4- Assistant professor, Department of Endodontics, Shool of Dentistry, Birjand University of Medical Sciences, Birjand, Iran. , soheiladarmiani@yahoo.com
Abstract:   (1791 Views)
Introduction: After Root Canal Treatment (RCT), pain control is a concern in dentistry. This double-blind study aimed to compare the efficacy of Celebrex (celecoxib) with placebo in controlling endodontic pain. We, therefore, investigated whether or not Celebrex for pain prevention following endodontic pain therapy is better than placebo. 
Materials and Methods: This randomized, double-blind study included 43 patients with symptomatic teeth. The patients consented to a prophylactic oral administration of 400mg of celecoxib, 400mg of Celebrex, or a placebo before RCT. The patients recorded their degree of pain intensity on a 170 mm Visual Analog Scale, immediately postoperative, and at time intervals of 4, 8, 12, 24, and 48h after treatment. The SPSS V. 16 (SPSS Inc. Chicago, USA) was used for statistical analysis. The data were analyzed by the Mann-Whitney and Freidman tests and Significance level was set at 0.05.
Results: There was no significant difference between celecoxib and placebo group (P>0.05), whereas the mean pain score was always lower for the celecoxib versus placebo group. The prophylactic Celebrex administration significantly reduced post-endodontic pain after initiation of RCT comparing with celecoxib and placebo group. 
Conclusion: The results of the study demonstrate that the Celebrex may be more effective than celecoxib for the management of postoperative endodontic pain.
Full-Text [PDF 681 kb]   (506 Downloads) |   |   Full-Text (HTML)  (498 Views)  
Type of Study: Original article | Subject: So on
Received: 2018/02/3 | Accepted: 2018/07/10 | Published: 2018/09/1

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Journal of Dentomaxillofacial

Designed & Developed by : Yektaweb